Mycobacterium Citations List: April 2024

Literature Citations

1. A Dual-targeting Succinate Dehydrogenase and F(1)F(o)-ATP Synthase Inhibitor Rapidly Sterilizes Replicating and Non-replicating Mycobacterium tuberculosis. Adolph, C., C.Y. Cheung, M.B. McNeil, W.J. Jowsey, Z.C. Williams, K. Hards, L.K. Harold, A. Aboelela, R.S. Bujaroski, B.J. Buckley, J.D.A. Tyndall, Z. Li, J.D. Langer, L. Preiss, T. Meier, A.J.C. Steyn, K.Y. Rhee, M. Berney, M.J. Kelso, and G.M. Cook. Cell Chemical Biology, 2024. 31(4): p. 683-698. PMID[38151019].
[PubMed]. TB_04_2024.

2. Novel 4-nitroimidazole Analogues: Synthesis, In Vitro Biological Evaluation, In Silico Studies, and Molecular Dynamics Simulation. Al-Soud, Y.A., S.O. Al-Sawakhnah, R.A. Al-Qawasmeh, N.A. Al-Masoudi, A.H. Al-Ahmad, L. Al-Maliki, L. van Geelen, R. Kalscheuer, B.A. Saeed, A. Shtaiwi, and H. Stark. Zeitschrift fur Naturforschung Section C Journal of Biosciences, 2024. 79(3-4): p. 61-71. PMID[38578162].
[PubMed]. TB_04_2024.

3. Activity Against Mycobacterium tuberculosis of a New Class of Spirooxindolopyrrolidine Embedded Chromanone Hybrid Heterocycles. Alkaltham, M.F., A.I. Almansour, N. Arumugam, S.K. Vagolu, T. Tønjum, S.I. Alaqeel, S. Rajaratnam, and V. Sivaramakrishnan. RSC Advances, 2024. 14(17): p. 11604-11613. PMID[38605893]. PMCID[PMC11008671].
[PubMed]. TB_04_2024.

4. Design, Synthesis and In Silico Molecular Docking Evaluation of Novel 1,2,3-triazole Derivatives as Potent Antimicrobial Agents. Baddam, S.R., M.K. Avula, R. Akula, V.R. Battula, S. Kalagara, R. Buchikonda, S. Ganta, S. Venkatesan, and T.R. Allaka. Heliyon, 2024. 10(7): e27773. PMID[38590856]. PMCID[PMC10999864].
[PubMed]. TB_04_2024.

5. Na(2)S(2)O(3) Catalyzed Three-component Synthesis and Anti-bacterial Activity of 3-methyl-4-(hetero)arylmethylene isoxazole-5(4H)-ones. Bi, Y., J. Wang, X. Bian, M. Chen, G. Zhu, Y. Zhang, and Q. Gu. Chemistry Biodiversity, 2024. 21(4): e202400073. PMID[38366673].
[PubMed]. TB_04_2024.

6. Efficacy of SPR720 in Murine Models of Non-tuberculous Mycobacterial Pulmonary Infection. Cotroneo, N., S.S. Stokes, M.J. Pucci, A. Rubio, K.A. Hamed, and I.A. Critchley. Journal of Antimicrobial Chemotherapy, 2024. 79(4): p. 875-882. PMID[38394463]. PMCID[PMC10984946].
[PubMed]. TB_04_2024.

7. Synthesis and Kinetic Evaluation of Phosphomimetic Inhibitors Targeting Type B Ribose-5-phosphate Isomerase from Mycobacterium tuberculosis. Courtiol-Legourd, S., S. Mariano, J. Foret, A.K. Roos, S.L. Mowbray, and L. Salmon. Bioorganic & Medicinal Chemistry Letters, 2024. 102: 129666. PMID[38382679].
[PubMed]. TB_04_2024.

8. An Evaluation of the Antibacterial, Antileishmanial, and Cytotoxic Potential of the Secondary Metabolites of Streptomyces sp. ARH (A3). de Azevedo, V.L.S., F.C. Rosa, L.R.L. Dias, L.A. Batista, M.C. Melo, L.A.T. Sales, A.J.M. Branco, T.R.R. Araújo, R.C.M. de Miranda, and A. Aliança. Microorganisms, 2024. 12(3). PMID[38543527]. PMCID[PMC10972310].
[PubMed]. TB_04_2024.

9. Triple Combination Dry Powder Formulation of Pretomanid, Moxifloxacin, and Pyrazinamide for Treatment of Multidrug-resistant Tuberculosis. Fan, C., B.B. Eedara, S. Sinha, M.K.M. Uddin, C. Doyle, S. Banu, and S.C. Das. International Journal of Biological Macromolecules, 2024. 654: 123984. PMID[38461874].
[PubMed]. TB_04_2024.

10. Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di-N-oxides Containing an Amino Acidic Side Chain. González, J.F., M.A. Dea-Ayuela, L. Huck, J.M. Orduña, F. Bolás-Fernández, E. de la Cuesta, N. Haseen, A.A. Mohammed, and J.C. Menéndez. Pharmaceuticals, 2024. 17(4). PMID[38675447]. PMCID[PMC11054274].
[PubMed]. TB_04_2024.

11. Bactericidal Permeability-increasing Protein (BPI) Inhibits Mycobacterium tuberculosis Growth. Guzmán-Beltrán, S., E. Juárez, B.L. Cruz-Muñoz, C.A. Páez-Cisneros, C. Sarabia, and Y. González. Biomolecules, 2024. 14(4). PMID[38672491]. PMCID[PMC11048543].
[PubMed]. TB_04_2024.

12. In Vitro and Ex Vivo Activity of the Fluoroquinolone DC-159a Against Mycobacteria. Imperiale, B.R., M.B. Mancino, R.D. Moyano, S. de la Barrera, and N.S. Morcillo. The Journal of Antibiotics, 2024. 77(5): p. 306-314. PMID[38438500].
[PubMed]. TB_04_2024.

13. Polycationic Phosphorous Dendrimer Potentiates Multiple Antibiotics Against Drug-resistant Mycobacterial Pathogens. Imran, M., S. Singh, M.N. Ahmad, P. Malik, A. Mukhopadhyay, K.S. Yadav, U.D. Gupta, M.N. Mugale, K. Mitra, K.K. Srivastava, S. Chopra, S. Mignani, E. Apartsin, J.P. Majoral, and A. Dasgupta. Biomedicine & Pharmacotherapy, 2024. 173: 116289. PMID[38452653].
[PubMed]. TB_04_2024.

14. New Benzotriazole Derivatives: Synthesis, Biological Assessment, In Vivo Oral Toxicity Analysis, Docking Studies, Molecular Dynamics, and ADME Profiling. Maiti, N.J., S. Ganguly, B. Sarkar, and R. Saha. Indian Journal of Heterocyclic Chemistry, 2023. 33(4): p. 489-497. ISI[001195331600014].
[WOS]. TB_04_2024.

15. Antimicrobial Effect of Cannabidiol on Intracellular Mycobacterium tuberculosis. Martinena, C.B., M. Corleto, M.M.B. Martínez, N.O. Amiano, V.E. García, P.C. Maffia, and N.L. Tateosian. Cannabis and Cannabinoid Research, 2024. 9(2): p. 464-469. PMID[38252548].
[PubMed]. TB_04_2024.

16. Fucoidan Coated Liposomes Loaded with Novel Antituberculosis Agent: Preparation, Evaluation, and Cytotoxicity Study. Obiedallah, M.M., V.V. Melekhin, Y.A. Menzorova, E.T. Bulya, A.S. Minin, and M.A. Mironov. Pharmaceutical Development and Technology, 2024. 29(4): p. 311-321. PMID[38529643].
[PubMed]. TB_04_2024.

17. Ethambutol and Meropenem/Clavulanate Synergy Promotes Enhanced Extracellular and Intracellular Killing of Mycobacterium tuberculosis. Olivença, F., D. Pires, C. Silveiro, B. Gama, F. Holtreman, E. Anes, and M.J. Catalão. Antimicrobial Agents and Chemotherapy, 2024. 68(4): e0158623. PMID[38411952]. PMCID[PMC10989012].
[PubMed]. TB_04_2024.

18. Critical View on Antimicrobial, Antibiofilm and Cytotoxic Activities of Quinazolin-4(3H)-one Derived Schiff Bases and their Cu(II) Complexes. Pindjakova, D., S. Mascaretti, J. Hricoviniova, J. Hosek, J. Gregorova, J. Kos, A. Cizek, Z. Hricoviniova, and J. Jampilek. Heliyon, 2024. 10(7): e29051. PMID[38601653]. PMCID[PMC11004567].
[PubMed]. TB_04_2024.

19. Design, Synthesis, Biological Evaluation and Docking Analysis of Pyrrolidine-Benzenesulfonamides as Carbonic Anhydrase or Acetylcholinesterase Inhibitors and Antimicrobial Agents. Poyraz, S., H.A. Döndaş, C. Yamali, S. Belveren, Y. Demir, S. Aydınoglu, N.Y. Döndaş, T. Taskin-Tok, S. Taş, M. Ülger, and J.M. Sansano. Journal of Biomolecular Structure and Dynamics, 2024. 42(7): p. 3441-3458. PMID[37232497].
[PubMed]. TB_04_2024.

20. Synthesis, Antitubercular Profile and Molecular Docking Studies of Quinazolinone-based Pyridine Derivatives Against Drug-resistant Tuberculosis. Raghu, M.S., K. Yogesh Kumar, T. Shamala, F.A. Alharti, M.K. Prashanth, and B.H. Jeon. Journal of Biomolecular Structure and Dynamics, 2024. 42(7): p. 3307-3317. PMID[37261798].
[PubMed]. TB_04_2024.

21. Synthesis and Biological Evaluation of New Naphthalimide-thiourea Derivatives as Potent Antimicrobial Agents Active Against Multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis. Rana, P., R. Parupalli, A. Akhir, D. Saxena, R. Maitra, M. Imran, P. Malik, S. Mahammad Ghouse, S.V. Joshi, D. Srikanth, Y.V. Madhavi, A. Dasgupta, S. Chopra, and S. Nanduri. RSC Medicinal Chemistry, 2024. 15(4): p. 1381-1391. PMID[38665829]. PMCID[PMC11042119].
[PubMed]. TB_04_2024.

22. Antitubercular Activity of 2-mercaptobenzothiazole Derivatives Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase. Saha, P., S. Sau, N.P. Kalia, and D.K. Sharma. RSC Medicinal Chemistry, 2024. ISI[001204233300001].
[WOS]. TB_04_2024.

23. Small Peptide Conjugates of Benzothiazole-2-Carboxylic Acids Targeting DprE1 Against Tuberculosis. Samoon, R., S. Sau, A. Khan, I. Latief, N.P. Kalia, M.Z. Abdin, and S. Shafi. ChemistrySelect, 2024. 9(15): e202400320. ISI[001202427000001].
[WOS]. TB_04_2024.

24. Identification and Characterization of Repurposed Small Molecule Inhibitors of Mycobacterium tuberculosis Caseinolytic Protease B (ClpB) as Anti-mycobacterials. Singh, D., R. Sharma, S. Jamal, M. Agarwal, S. Grover, and J.K. Batra. International Journal of Biological Macromolecules, 2024. 264(Pt 1): 130614. PMID[38447849].
[PubMed]. TB_04_2024.

25. Structure-guided Identification and Characterization of Potent Inhibitors Targeting PhoP and MtrA to Combat Mycobacteria. Su, H.L., S.J. Lai, K.C. Tsai, K.M. Fung, T.L. Lung, H.M. Hsu, Y.C. Wu, C.H. Liu, H.X. Lai, J.H. Lin, and T.S. Tseng. Computational and Structural Biotechnology Journal, 2024. 23: p. 1477-1488. PMID[38623562]. PMCID[PMC11016868].
[PubMed]. TB_04_2024.

26. Trifluoroacetic Acid-mediated Synthesis of Xanthene Constructs and Their Extensive Anti-tuberculosis Evaluation. Teli, B., M.M. Mubarak, Z. Ahmad, and B.A. Bhat. RSC Medicinal Chemistry, 2024. 15(4): p. 1295-1306. PMID[38665820]. PMCID[PMC11042163].
[PubMed]. TB_04_2024.

27. Design, Synthesis and Characterization of Ethyl 3-benzoyl-7-morpholinoindolizine-1-carboxylate as Anti-tubercular Agents: In Silico Screening for Possible Target Identification. Tiwari, P., G.S. Mangubhai, S. Kidwai, R. Singh, and S. Chandrashekharappa. Chemical Biology & Drug Design, 2024. 103(4): e14512. PMID[38570316].
[PubMed]. TB_04_2024.

28. Synthesis, Antifungal, and Anti-tubercular Activity of some New 7-amino-2-(substituted aryl)-5-oxo-1,5-dihydro-[1,2,4]triazolo[1,5-a]pyridine-6-carbonitrile Derivatives. Visampalli, P., G. Vedula, M. Sharmila, and B. Dwarampudi. Indian Journal of Heterocyclic Chemistry, 2023. 33(4): p. 465-471. ISI[001195331600011].
[WOS]. TB_04_2024.

29. Molecular Modeling and Biological Investigation of Novel S-triazine Linked Benzothiazole and Coumarin Hybrids as Antimicrobial and Antimycobacterial Agents. Zala, A.R., D. Kumar, U. Razakhan, D.P. Rajani, I. Ahmad, H. Patel, and P. Kumari. Journal of Biomolecular Structure and Dynamics, 2024. 42(7): p. 3814-3825. PMID[37218082].
[PubMed]. TB_04_2024.

Patent Citations

30. Troponoids as antimycobacterial agents for treating mycobacterial diseases. Abate, G., J. Tavis, D.W. Griggs, and R. Murelli. Patent. 2024. US2023-470317 20240115521: 30pp.
[Patent]. TB_04_2024.

31. Nitrobenzamide compounds, methods and uses thereof. Vicente Constantino, L.F., J.P. Almeida Pais, T.A. Duarte Delgado, O. Antoniuk, R. Martins da Silva, E.M. Ribeiro dos Santos Anes, and D.A. Rodrigues Pires. Patent. 2024. EP2022-199255 4345092: 32pp.
[Patent]. TB_04_2024.

32. Benzoic acid derivatives, methods and uses thereof in mycobacterial infections. Vicente Constantino, L.F., J.P. Almeida Pais, T.A. Duarte Delgado, O. Antoniuk, E.M. Ribeiro dos Santos Anes, and D.A. Rodrigues Pires. Patent. 2024. EP2022-199251 4345091: 36pp.
[Patent]. TB_04_2024.